Deka Bank Deutsche Girozentrale Recursion Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

  • $53.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
BUY
$7.83 - $13.6 $168,345 - $292,400
21,500 Added 55.84%
60,000 $651,000
Q2 2022

Aug 03, 2022
BUY
$5.04 - $9.26 $194,040 - $356,510
38,500 New
38,500 $310,000
Q1 2022

Apr 28, 2022
SELL
$6.16 - $18.03 $215,600 - $631,050
-35,000 Closed
0 $0
Q4 2021

Feb 02, 2022
BUY
$16.14 - $21.86 $564,900 - $765,100
35,000 New
35,000 $592,000

Others Institutions Holding RXRX

# of Institutions
286
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.38B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email